October edition of Australian Prescriber out now
Plenty of treatment options for irritable bowel syndrome, but diagnosis is crucial
Dr Chamara Basnayake, a gastroenterologist at St Vincent’s Hospital in Melbourne, says irritable bowel syndrome is very common but not always recognised. People with symptoms may benefit from simple non-drug interventions discussed in the article.
Medical management of metastatic prostate cancer means doubled life expectancy for some men
This article details the management of advanced metastatic prostate cancer. Metastatic castrate-resistant disease is now considered a chronic illness as the life expectancy of some patients has almost doubled due to new treatments.
Other articles in the October issue of Australian Prescriber include:
- Medicine shortages in Australia
- Second steps in managing type 2 diabetes
- Drugs for benign prostatic hypertrophy
- Dry eye disease: when to treat and when to refer
- New drugs: benralizumab for asthma, dulaglutide for type 2 diabetes, glecaprevir/pibrentasvir for hepatitis C, ribociclib for breast cancer, and trifluridine/tipiracil for colorectal cancer
02 8217 8733, 0419 618 365 or [email protected]
Australian Prescriber is an independent peer-reviewed journal providing critical commentary on therapeutic topics for health professionals. It is published by NPS MedicineWise, an independent, not-for-profit organisation for quality use of medicines funded by the Australian Government Department of Health. Australian Prescriber is published every two months and is available online at nps.org.au/australianprescriber